Back to Search
DANIEL FERRARIS, DMD
DMD
General Practice Dentistry
NPI: 1508977919Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
0160000696(VT)
Research & Publications (17)
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.
PMID 19217074·Biol Psychiatry·2009
7-preclinical
Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
PMID 18507366·J Med Chem·2008
7-preclinical
Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase.
PMID 17596215·J Neurochem·2007
8-other
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV).
PMID 17352680·Curr Top Med Chem·2007
6-review
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).
PMID 17581113·Biochem J·2007
7-preclinical
Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB.
PMID 17662939·Cell·2007
8-other
DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
PMID 15925329·Brain Res·2005
4-observational
Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels.
PMID 15561722·J Biol Chem·2005
8-other
Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
PMID 15458385·Biochem J·2005
8-other
Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors.
PMID 15482928·Bioorg Med Chem Lett·2004
7-preclinical
Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries.
PMID 12901915·Bioorg Med Chem·2003
7-preclinical
Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Part 3: In vitro evaluation of 1,3,4,5-tetrahydro-benzo[c][1,6]- and [c][1,7]-naphthyridin-6-ones.
PMID 12852955·Bioorg Med Chem Lett·2003
8-other
Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
PMID 12825952·J Med Chem·2003
7-preclinical
The development of the first catalyzed reaction of ketenes and imines: catalytic, asymmetric synthesis of beta-lactams.
PMID 12047183·J Am Chem Soc·2002
8-other
Catalytic, enantioselective alkylation of alpha-imino esters: the synthesis of nonnatural alpha-amino acid derivatives.
PMID 11772063·J Am Chem Soc·2002
8-other
Synthesis of substituted 5[H]phenanthridin-6-ones as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors.
PMID 11425538·Bioorg Med Chem Lett·2001
8-other
Ion exchange chromatographic determination of olpadronate, phosphate, phosphite, chloride and methanesulfonic acid.
PMID 11248496·J Pharm Biomed Anal·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 60 TIMBER LN
SOUTH BURLINGTON, VT 05403 - Phone
- (802) 264-6909
Quick Facts
- NPI
- 1508977919
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile